Dr Reddys Laboratories (RDY) Total Debt Growth (1y) (2010 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Total Debt Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.91 Bn | 2.15 Bn | -3.69% |
| 2 | Viatris | 19.14 Bn | 18.26 Bn | 1.46 Bn | -7.75% |
| 3 | Dr Reddys Laboratories | 9.89 Bn | 9.71 Bn | 396.53 Mn | 60.10% |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | 8.22% |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | -4.47% |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | -4.20% |
| 8 | Amphastar Pharmaceuticals | 994.43 Mn | 704.31 Mn | 93.47 Mn | 0.56% |
| 9 | Fennec Pharmaceuticals | 401.07 Mn | 359.82 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 179.86 Mn | 179.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.10% |
| Mar 31, 2026 | 73.82% |
| Dec 31, 2025 | 34.46% |
| Sep 30, 2025 | 6.99% |
| Jun 30, 2025 | 44.17% |
| Mar 31, 2025 | 135.28% |
| Dec 31, 2024 | 166.49% |
| Sep 30, 2024 | 253.48% |
| Jun 30, 2024 | 129.74% |
| Mar 31, 2024 | 113.70% |
| Dec 31, 2023 | -3.26% |
| Sep 30, 2023 | -26.20% |
| Jun 30, 2023 | -58.26% |
| Mar 31, 2023 | -75.85% |
| Dec 31, 2022 | -39.19% |
| Sep 30, 2022 | -47.70% |
| Jun 30, 2022 | -20.01% |
| Mar 31, 2022 | 8.11% |
| Dec 31, 2021 | 36.42% |
| Sep 30, 2021 | 12.58% |